联系我们

国际针灸合作委员会关于变更办公地址的通知

中国民间中医医药研究开发协会国际针灸合作委员会

办公地点现在已经搬迁至西城区西直门南小街国英园一号楼824室,

同时为方便大家联系,固定电话已经变更

新号码010—58562339。特此通知。

地址:北京西城区西直门南小街国英园一号楼824室

邮编:100035

电话:010-58562339

传真:010-58562339

邮箱:cngjzj@163.com

网站(点击网址直接链接↓):http://www.cngjzj.com/

博客(点击网址直接链接↓):http://blog.sina.com.cn/cngjzj

交通路线图 (点击观看大图)

到西城区西直门南小街国英园一号楼行驶路线

机场线路1

从首都机场乘坐机场专线,在东直门站下车换乘地铁2号线开往西直门方向,在西直门站 C 口出站:

1、沿西直门内大街向东直行100米,右拐到西直门南小街,向南步行到丁字路口即到国英园1号楼楼下。

2、向南直行50米,绕过 国二招宾馆 沿着中大安胡同向东到西直门南小街,向南步行到丁字路口即到国英园1号楼楼下。

机场线路2

从首都机场内乘坐机场直达西单的大巴,在西单站下车,乘坐出租车到西直门南小街国英园1号楼。

附近公交地铁:

公交官园站:107路,运通106路

公交西直门南:387路,44路,800内环,816路,820内环,845路

地铁车公庄:地铁二号线

地铁西直门:地铁二号线

公交车公庄东:107路,118路,701路

公交车公庄北:209路,375路,392路

您现在的位置是: 首页 >> Regulations >> Regulations

About print and distribute the first encourage r&d declare children drug list notification

2016年06月02日

复制链接 打印 大 中 小

<



About print and distribute the first encourage r&d declare children drug list notification

The national health and family planning commission of the People's Republic of China

The 2016-06-01

Countries who do drug administration letter [2016] no. 573


Provinces, autonomous regions and municipalities directly under the central government health and family planning commission (bureau), the competent department of industry and information technology, food and drug supervision bureau, the xinjiang production and construction corps health bureau, ministry of industry and information technology commission, the food and drug supervision bureau:

In 2016, according to central comprehensively deepen reform leading group office key reform tasks arrangement, to deepen the reform, further do a good job and ensure children, promote children adapted varieties, dosage form, specification development initiatives and declare the review, meet the demand of pediatric clinical medication, the national health and family planning commission, the ministry of industry and information technology, food and drug supervision administration organization experts made the list of the first encourage r&d to declare the children's medicine. Hereby printed and distributed to you, please push related work.

General office of the national health and family planning commission general office of the ministry of industry and information technology

The food and drug supervision administration office

On May 31, 2016

The first to encourage r&d to declare the children's medicine list

varieties

Dosage form

specifications

Benzene hai suo

Oral elixir

0.4 mg/ml

Phenytoin sodium

injection

50 mg/ml (5 ml)

digoxin

injection

0.05 mg/ml (1 ml)

diazepam

enemas

1 mg/ml

Cefuroxime Sammy

Oral solution

4 mg/ml

haloperidol

Oral solution

2 mg/ml

captopril

Oral solution

5 mg/ml

lorazepam

injection

2 mg/ml (1 ml)

clonazepam

Oral solution

0.1 mg/ml

midazolam

Solution of the oral mucosa

5 mg/ml (1 ml)

Nim horizon

Oral solution

3 mg/ml

propranolol

Oral solution

1 mg/ml

adrenaline

injection

0.1 mg/ml (1 ml)

Sodium bicarbonate

injection

1.4% (100 ml)

Chloral hydrate

Oral solution, oral suspension liquid or intestinal juice

diazoxide

Oral solution

50 mg/ml (30 ml)

Vinblastine (VLB)

injection

1 mg

Phenylalanine nitrogen mustard (flange)

injection

50 mg

mercaptopurine

Oral suspension liquid

20 mg/ml

warfarin

Oral suspension liquid

1 mg/ml

Bear to oxygen cholic acid

Oral suspension liquid

50 mg/ml

B raschig left temple

injection

500 mg / 5 ml

isoniazid

syrups

10 mg/ml

Willow nitrogen sulfonyl pyridine

Oral suspension liquid

50 mg/ml

rifampicin

Oral suspension liquid

20 mg/ml

Human recombinant parathyroid hormone

injection

20 ug

glucagon

injection

1 mg

Polymyxin E

Oral preparations

Insulin-like growth factor 1

injection

10 mg

DHT

injection

20 mg

DHT

gel

80 g

Corticotrophin (ACTH)

injection

Iu 40, 80 iu

Note: drug indications should include pediatric indications or with children's usage and dosage.